title: The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.
abstract: The placebo effect of a psychoactive drug can be defined as the effect of expecting the drug in the absence of its pharmacological actions. As nicotine is widely believed to be the primary factor driving cigarette smoking, smokers are likely to expect nicotine to alleviate craving and withdrawal. The present review examines the extent to which any observed effects of nicotine, and especially its craving- and withdrawal-reducing effects, can be attributed to placebo. We begin by reviewing studies that examined the placebo effects of nicotine in the laboratory and follow with a review of potential placebo effects that are typically not controlled in placebo-controlled studies of nicotine replacement therapy (NRT). In laboratory studies, nicotine instructions decrease tobacco smoking, craving and/or withdrawal, while nicotine-specific effects have not been consistently reported. In field trials of NRT, there is a general failure to assess smokers' beliefs regarding their drug assignment. This omission makes it difficult to unequivocally attribute findings of placebo-controlled NRT studies to the physiological effects of nicotine. In sum, our review indicates that the placebo effects of nicotine, and specifically nicotine content expectations, may account for many of the benefits associated with nicotine delivery devices in both laboratory and field studies.
authors.affiliation: School of Psychological Sciences, Tel Aviv University, Tel Aviv, Israel ruvidar@post.tau.ac.il.
authors.forename: Reuven
authors.initials: R
authors.lastname: Dar
authors.affiliation: Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.
authors.forename: Sean P
authors.initials: SP
authors.lastname: Barrett
mesh_terms: D000818:Animals; D016739:Behavior, Addictive / Q000188:drug therapy / Q000523:psychology*; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage* / Q000627:therapeutic use*; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D015990:Placebo Effect; D016540:Smoking Cessation / Q000523:psychology*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000523:psychology*; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000188:drug therapy / Q000523:psychology*
chemical_list: D018722:Nicotinic Agonists; D009538:Nicotine
keywords: Nicotine; balanced placebo design; denicotinized cigarettes; nicotine replacement therapy; placebo; smoking